TRIBUTE : a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
収録刊行物
-
- J Clin Oncol
-
J Clin Oncol 23 5892-5899, 2005